Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches. Issue 7 (2nd October 2022)

• Record Type: Journal Article
• Authors: McMillan, Corey T.; Wuu, Joanne; Rascovsky, Katya; Cosentino, Stephanie; Grossman, Murray; Elman, Lauren; Quinn, Colin; Rosario, Luis; Stark, Jessica H.; Granit, Volkan; Briemberg, Hannah; Chenji, Sneha; Dionne, Annie; Genge, Angela; Johnston, Wendy; Korngut, Lawrence; Shoesmith, Christen; Zinman, Lorne; Kalra, Sanjay; Benatar, Michael
• Is Part Of: Amyotrophic lateral sclerosis and frontotemporal degeneration. Volume 23:Issue 7/8(2022)
• Page Start: 517
• Page End: 526
• Publication Date: 2022-10-02
• Subjects: Cognition -- ECAS -- normative data -- neuropsychology -- ALS-FTD -- dementia -- biomarker -- risk; 616.839
• DOI: 10.1080/21678421.2022.2039713
• Languages: English
• ISSNs: 2167-8421

Abstract

Abstract: Objective : Amyotrophic lateral sclerosis (ALS) is a multi-system disorder characterized primarily by motor neuron degeneration, but may be accompanied by cognitive dysfunction. Statistically appropriate criteria for establishing cognitive impairment (CI) in ALS are lacking. We evaluate quantile regression (QR), that accounts for age and education, relative to a traditional two standard deviation (SD) cutoff for defining CI. Methods : QR of cross-sectional data from a multi-center North American Control (NAC) cohort of 269 healthy adults was used to model the 5 th percentile of cognitive scores on the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). The QR approach was compared to traditional two SD cutoff approach using the same NAC cohort (2SD-NAC) and to existing UK-based normative data derived using the 2SD approach (2SD-UK) to assess the impact of cohort selection and statistical model in identifying CI in 182 ALS patients. Results : QR-NAC models revealed that age and education impact cognitive performance on the ECAS. Based on QR-NAC normative cutoffs, the frequency of CI in the 182 PENN ALS patients was 15.9% for ALS specific, 12.6% for ALS nonspecific, and 15.4% for ECAS total. This frequency of CI is substantially more conservative in comparison to the 2SD-UK (20.3%–34.6%) and modestly more conservative to the 2SD-NAC (14.3%–16.5%) approaches for estimating CI. Conclusions : The choice of normative cohort has a substantial impact and choice of statistical method a modest impact on defining CI in ALS. This report establishes normative ECAS thresholds to identify whether ALS patients in the North American population have CI.